Provider: View Press Release
Type: Link
Title: Medicines and Healthcare products Regulatory Agency authorises GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults | GSK
Description: Authorisation will help protect adults 60 years of age and older in the UK from RSV disease for the first time
Provider: View Press Release
Type: Link
Title: GSK completes acquisition of BELLUS Health | GSK
Description: BELLUS is a biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough.
Provider: View Press Release
Type: Link
Title: GSK receives US FDA Fast Track designation for investigational vaccine against gonorrhoea | GSK
Description: Fast Track designation accelerates the vaccine candidate’s path to US FDA submission for the prevention of Neisseria gonorrhoeae infection
Provider: View Press Release
Type: Link
Title: Japan’s Ministry of Health, Labour and Welfare approves Shingrix for the prevention of shingles in at-risk adults aged 18 and over | GSK
Description: Approval expands the number of people who can be protected against shingles.
Provider: View Press Release
Type: Link
Title: GSK receives positive CHMP opinion recommending authorisation of daprodustat for symptomatic anaemia associated with chronic kidney disease in adults on chronic maintenance dialysis | GSK
Description: The positive CHMP opinion is based on data from three global phase III trials in dialysis patients from the ASCEND clinical trial programme.
Provider: View Press Release
Type: Link
Title: Statement - Zantac (ranitidine) litigation | GSK
Description: GSK today confirmed it has reached a confidential settlement with James Goetz.